Evidence map›Paper›PMID 42527535›Full record

ArticlePediatric research2026

Process mapping to design theory-informed strategies reducing inappropriate HFNC use in emergency bronchiolitis care.

Louise Shaw, Catherine Wilson, Libby Haskell, Donna Franklin, Stuart Dalziel, Natalie Taylor, Meredith Borland, Sharon O'Brien, FranzE Babl, Emma Tavender

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Louise ShawEmergency Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia. louise.shaw@mcri.edu.au.
Catherine WilsonEmergency Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Libby HaskellChildren's Emergency Department, Starship Children's Hospital, Auckland, New Zealand.
Donna FranklinChildren's Emergency and Critical Care Research, Gold Coast University Hospital, Southport, QLD, Australia.
Stuart DalzielChildren's Emergency Department, Starship Children's Hospital, Auckland, New Zealand.
Natalie TaylorImplementation to Impact (i2i), School of Population Health, University of New South Wales, Sydney, NSW, Australia.
Meredith BorlandDivision of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, University of Western Australia, Crawley, WA, Australia.
Sharon O'BrienDivision of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, University of Western Australia, Crawley, WA, Australia.
FranzE BablEmergency Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Emma TavenderEmergency Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-flow nasal cannula (HFNC) in bronchiolitis is widely used beyond guideline recommendations. This study developed targeted, theory-informed implementation strategies to improve appropriate HFNC use in regional and rural emergency departments (EDs), to be evaluated in a cluster randomised controlled trial (cRCT).

methodsA 3-phase process mapping and implementation science approach was embedded in a clinician co-design study involving 12 senior clinicians (5 nurses, 7 doctors) from Australian regional and rural EDs. International and Australian literature informed discussions. Barriers were coded using the Theoretical Domains Framework (TDF) and Consolidated Framework for Implementation Research (CFIR 2.0) with strategy co-design guided by CFIR-ERIC and TDF-BCT linkages.

resultsFive HFNC decision nodes were identified: assessment of hypoxaemia, low-flow oxygen trial and reassessment, escalation to HFNC, weaning and cessation, and escalation of care. Behavioural factors included fear of deterioration, limited confidence in respiratory assessment, and norms favouring early escalation. Contextual factors included limited paediatric expertise, staff turnover, and unclear de-escalation. Findings informed strategies including targeted education, clinical pathways and audit and feedback.

conclusionsProcess mapping identified behavioural and contextual drivers of inappropriate HFNC use informing implementation strategies and offering a practical, scalable approach to translating guidelines into routine ED practice. IMPACT: This study identifies behavioural and contextual drivers of inappropriate high-flow nasal cannula use in infants with bronchiolitis across regional and rural emergency departments. Using structured process mapping and clinician co-design, we mapped decision-making at key clinical nodes and developed targeted, theory-informed implementation strategies to address identified barriers. Findings directly informed educational content and implementation strategies being evaluated in a cluster randomised controlled trial across 30 regional and rural hospitals. This work provides a practical, scalable framework for translating guidelines into routine emergency department practice, with relevance beyond bronchiolitis to other high-variation clinical behaviours in acute care.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.